A Novel, Personalized Drug-Screening System for Platinum-Resistant Ovarian Cancer Patients: A Preliminary Clinical Report

PURPOSE: With this study, we intended to construct a personalized drug-screening system for platinum-resistant ovarian cancer patients by consulting a patient’s medical history, data derived from gene mutation detection, and drug screening results derived from mini-PDX (patient-derived xenograft) mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yunke, Xu, Jing, Li, Ke, Wang, Jing, Dai, Yilin, Kang, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020460/
https://www.ncbi.nlm.nih.gov/pubmed/33833569
http://dx.doi.org/10.2147/CMAR.S276799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8020460/
https://www.ncbi.nlm.nih.gov/pubmed/33833569
http://dx.doi.org/10.2147/CMAR.S276799

Ejemplares similares